DCGI cancels import licences for rapid test kit of 3 companies, suspends that of 16 others
The three firms are Cadila Healthcare, MDAAC International and N W Overseas while the 16 companies include Transasia Bio-Medicals, Cosmic Scientific, Inbios India, S D Biosensor, Accurex Biomedicals, Biohouse Solutions and Trivitron Healthcare among others CADILA HEALTHCARE LTD. - 532321 - Covid-19 Impact
Covid-19 impact-disclosure as per SEBI Circular dated May 20, 2020
Cadila Healthcare shares gain after Zydus gets USFDA nod for cancer drug trials
The company has also initiated a Phase 2 trials of Desidustat in Mexico for COVID-19 patients. CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
'Zydus receives approval from USFDA to initiate clinical trials of Desidustat in cancer patients receiving chemotherapy'.
Draw up immunisation strategy now itself for COVID-19 vaccine: Kiran Mazumdar-Shaw
"If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by the end of the year," Mazumdar-Shaw said. Gennova to start human trials end of the year
Gennova to start human trials end of the yearPune-based biotechnology company Gennova Biopharmaceuticals will soon start human clinical trials of a Covid-19 vaccine candidate, joining Bharat Biotech, Zydus Cadila and many global peers in the race for a vaccine against the pandemic. Gennova is the first Indian company that is working on an mRNA vaccine platform that US-based biotech company Moderna's Covid-19 vaccine candidate is based. Gennova CEO Sanjay Singh shared the company's plans with ET's Divya Rajagopal in an interview. Edited excerpts follow. Stock query: Cadila Healthcare on medium-term uptrend
A strong rally beyond 400 will push it higher to the long-term trend-deciding level of 430 USFDA allows Zydus Cadila to sell generic drug for treating headaches
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tabletsin strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives final approval from USFDA for Butalbital, Acetaminophen and Caffeine Tablets Cadila Aims To Complete Trial Of Coronavirus Vaccine By March
Early-stage Phase 1 and 2 human trials are likely to be concluded in the next three months